Dezhan Healthcare Hits Day Low of CNY 3.81 Amid Price Pressure

Dezhan Healthcare Co., a mid-cap player in the Pharmaceuticals & Biotechnology sector, experienced significant volatility today, with its stock price dropping by 9.93%. The stock reached an intraday low of CNY 3.81, reflecting ongoing challenges within the company. Over the past week, Dezhan Healthcare's performance has declined by 3.05%, while its one-month performance shows a gain of 15.45%. However, this recent uptick contrasts sharply with its longer-term trajectory, as the stock has seen a 5-year decline of 28.92% and a staggering 62.35% drop over the past decade. Financial metrics indicate persistent difficulties, with a low Return on Capital Employed (ROCE) of 1.63%, suggesting limited profitability relative to capital employed. The company has reported negative net sales growth of 25.72% and has faced losses for seven consecutive quarters. With a market capitalization of CNY 8,791 million, Dezhan Healthcare continues to navigate a challenging landscape, marked by declining sales and profitability metrics.